ConvaTec Group PLC (CTEC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ConvaTec Group PLC (CTEC) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX155.00 Million ≈ $18.86K USD) by net assets (GBX1.81 Billion ≈ $220.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CTEC net asset quality score to measure how much of total assets are equity-financed.
ConvaTec Group PLC - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how ConvaTec Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ConvaTec Group PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
ConvaTec Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ConvaTec Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
WI Co. Ltd.
KQ:073570
|
-0.030x |
|
Hansol Csn
KO:009180
|
0.030x |
|
Blue Lagoon Resources Inc
F:7BL
|
-0.071x |
|
Thonburi Medical Centre Public Company Limited
BK:KDH
|
0.051x |
|
Yesil Gayrimenkul Yatirim Ortakligi AS
IS:YGYO
|
0.005x |
|
CSL Finance Limited
NSE:CSLFINANCE
|
-0.081x |
|
Ahoku Electronic Co
TW:3002
|
-0.016x |
|
Top Win International Limited
NASDAQ:SORA
|
-0.540x |
Annual Cash Flow Conversion Efficiency for ConvaTec Group PLC (2013–2024)
The table below shows the annual cash flow conversion efficiency of ConvaTec Group PLC from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see CTEC market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX1.69 Billion ≈ $205.49K |
GBX396.20 Million ≈ $48.21K |
0.235x | +8.08% |
| 2023-12-31 | GBX1.69 Billion ≈ $205.95K |
GBX367.40 Million ≈ $44.70K |
0.217x | +24.03% |
| 2022-12-31 | GBX1.61 Billion ≈ $195.85K |
GBX281.70 Million ≈ $34.27K |
0.175x | -3.04% |
| 2021-12-31 | GBX1.69 Billion ≈ $206.21K |
GBX305.90 Million ≈ $37.22K |
0.180x | -24.52% |
| 2020-12-31 | GBX1.67 Billion ≈ $203.28K |
GBX399.50 Million ≈ $48.61K |
0.239x | -7.10% |
| 2019-12-31 | GBX1.56 Billion ≈ $189.93K |
GBX401.80 Million ≈ $48.89K |
0.257x | +18.26% |
| 2018-12-31 | GBX1.62 Billion ≈ $196.77K |
GBX352.00 Million ≈ $42.83K |
0.218x | +8.18% |
| 2017-12-31 | GBX1.52 Billion ≈ $185.40K |
GBX306.60 Million ≈ $37.30K |
0.201x | +234.77% |
| 2016-12-31 | GBX1.25 Billion ≈ $151.63K |
GBX74.90 Million ≈ $9.11K |
0.060x | +113.11% |
| 2015-12-31 | GBX-218.80 Million ≈ $-26.62K |
GBX100.30 Million ≈ $12.20K |
-0.458x | -576.75% |
| 2014-12-31 | GBX-2.17 Billion ≈ $-264.59K |
GBX147.30 Million ≈ $17.92K |
-0.068x | +36.95% |
| 2013-12-31 | GBX-2.13 Billion ≈ $-259.46K |
GBX229.10 Million ≈ $27.87K |
-0.107x | -- |
About ConvaTec Group PLC
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more